endophthalmitis
Information
- Disease name
- endophthalmitis
- Disease ID
- DOID:4692
- Description
- "A globe disease that is characterized by inflammation of the inside of the eye." [url:http\://en.wikipedia.org/wiki/Endophthalmitis, url:http\://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&va=endophthalmitis, url:https\://www.merckmanuals.com/home/eye-disorders/uveitis-and-related-disorders/endophthalmitis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT03968341 | Active, not recruiting | N/A | Study of Intraocular Concentrations (Aqueous Humor, Vitreous Humor) of Antibiotics After Local and/or Systemic Administration in Endophthalmitis | December 9, 2020 | December 8, 2023 |
NCT00136344 | Completed | N/A | Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery | September 2003 | May 2006 |
NCT05249413 | Completed | Early Vitrectomy for Endophthalmitis After Cataract Surgery | January 2, 2015 | January 15, 2022 | |
NCT00398658 | Completed | Phase 4 | Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis | March 2002 | December 2004 |
NCT00406913 | Completed | N/A | Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery | October 2005 | November 2006 |
NCT00461656 | Completed | Phase 4 | Povidone-iodine Antisepsis for Strabismus Surgery | September 2009 | December 2012 |
NCT00730938 | Completed | N/A | The Effect of Intracameral Cefuroxime on Post-op Fibrin in Pediatric Cataract Surgery | February 2008 | August 2008 |
NCT01323868 | Completed | Endogenous Endophthalmitis in the Inpatient Setting | July 2010 | June 2013 | |
NCT04568213 | Completed | Phase 3 | Hypochlorous Acid Disinfection Prior to Cataract Surgery | October 29, 2020 | December 9, 2022 |
NCT04403334 | Completed | Phase 4 | Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin | January 2, 2018 | April 28, 2018 |
NCT04192994 | Completed | N/A | Evaluation do Early Pars Plana Vitrectomy in Acute Endophthalmitis | January 1, 2019 | December 1, 2023 |
NCT02595359 | Completed | Phase 2 | Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis | January 2013 | June 20, 2018 |
NCT03363295 | Completed | Phase 4 | Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis | July 1, 2017 | December 30, 2019 |
NCT02818062 | Completed | Severe Intraocular Infection | January 2008 | September 2011 | |
NCT00000130 | Completed | Phase 3 | Endophthalmitis Vitrectomy Study (EVS) | February 1990 | January 1995 |
NCT03244072 | Not yet recruiting | Phase 2/Phase 3 | Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery | June 1, 2024 | October 2025 |
NCT05432336 | Recruiting | Complex Ocular Infection, Optimization of Microbiological Diagnosis | November 21, 2023 | May 2025 | |
NCT05372861 | Recruiting | Nanopore Sequencing in Ophthalmology | April 22, 2022 | December 1, 2024 | |
NCT06268561 | Recruiting | Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months | June 5, 2023 | June 2024 | |
NCT04035369 | Recruiting | N/A | Endophthalmitis Post Intravitreal Injections | March 1, 2020 | July 2024 |
NCT02590523 | Suspended | Phase 3 | Intracameral Antibiotic Safety Study | January 2023 | January 2024 |
NCT02770729 | Terminated | Phase 3 | Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis. | January 2017 | May 7, 2018 |
NCT01496794 | Terminated | Endophthalmitis Cultures | October 2011 | April 2016 | |
NCT05162625 | Unknown status | Phase 2 | Safety and Efficacy of Topical Moxifloxacin for Prevention of Post-Traumatic Endophthalmitis: Randomized Controlled Clinical Trial | December 10, 2021 | December 10, 2023 |
NCT04214821 | Unknown status | Phase 1/Phase 2 | The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5% | September 23, 2019 | May 2022 |
NCT03420820 | Unknown status | N/A | Concentrating on Antisepsis: 5% vs. 10% Povidone-Iodine Prior to Intravitreal Injection | March 1, 2018 | July 1, 2018 |
NCT03812640 | Unknown status | N/A | Nylon Verus Polyglactin Corneal Suture in Pediatric Cataract Surgery | January 1, 2019 | October 1, 2019 |
NCT04075669 | Unknown status | Multiplex Strip Polymerase Chain Reaction for Diagnosis of Eye Infection Diseases From Corneal Scraping Samples | August 1, 2019 | June 2020 | |
NCT02324166 | Unknown status | Phase 4 | Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain | January 2015 | January 2016 |
NCT02810587 | Unknown status | Endophthalmitis After Intravitreous Anti-VEGF Injections in Patients Receiving vs. Not Receiving Topical Antibiotics | May 2015 | April 2017 | |
NCT05079854 | Unknown status | Phase 4 | Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis | October 1, 2021 | November 1, 2023 |
NCT00335231 | Withdrawn | N/A | Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery | June 2006 | June 2013 |
NCT02309736 | Withdrawn | OTX-14-002: Device Exposure Registry |
- Disase is a (Disease Ontology)
- DOID:1242
- Cross Reference ID (Disease Ontology)
- MESH:D009877
- Cross Reference ID (Disease Ontology)
- NCI:C34586
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:1847009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0014236
- MeSH unique ID (MeSH (Medical Subject Headings))
- D009877